skip to main content

The thing that strikes you the most about Paul, Weiss is the depth of the practice. They just have a large number of senior partners, all of whom are of an outstanding quality.

- Chambers USA, Band 1 for Bankruptcy/Restructuring (Nationwide and NYC) and "Bankruptcy Law Firm of the Year" in 2019

Healthcare & Pharmaceutical

Our restructuring department fields large, multidisciplinary teams that leverage the resources of our firm as a whole. We act on all sides of cutting-edge restructuring transactions across a range of industries.

resource search icon
  • Chapter 11 Cases of Endo Pharmaceuticals

    An ad hoc group of first lien, second lien, and unsecured lenders in the chapter 11 restructuring of Endo Pharmaceuticals, a specialty pharmaceutical company. The group comprised approximately of $3.2 billion, nearly forty percent, of the company’s funded debt.

  • Envision Healthcare Financing

    KKR, as sponsor to Envision Healthcare, in connection with Envision’s entry into $2.6 billion, in aggregate, of new senior secured first and second lien financing facilities and its $1.5 billion of related discounted debt repurchase transactions and $3.7 billion refinancing transaction.

  • The Stayton

    The successor bond trustee and an ad hoc group of certain holders of Tarrant County Cultural Education Facilities Financial Corporation Retirement Revenue Bonds (The Stayton at Museum Way Project), Series 2020 Bonds, in connection with safeguarding their interests in respect of Series 2020 Bonds and The Stayton, a continuing care retirement community.

  • Bausch Healthcare Spin-Off

    An ad hoc group of secured and unsecured creditors of Bausch Health, a multinational healthcare company, in connection with the company’s proposed spin-off of its eyecare business.

  • Mallinckrodt's Restructuring

    An ad hoc committee of noteholders of Mallinckrodt, a leading global biopharmaceutical company, in (a) Mallinckrodt’s chapter 11 cases and (b) a prior out-of-court exchange of $495 million of senior unsecured debt for new first lien senior secured notes, on a par-for-par basis.

  • The Medicines Company Chapter 11

    The Medicines Company, a leading biopharmaceutical company, as one of the largest unsecured creditors in the chapter 11 cases of Melinta Therapeutics, a pharmaceutical company focused on antibiotic medicines.

  • One Call Medical's Out-of-Court Restructuring

    Chatham Asset Management in an out-of-court restructuring of One Call Corporation, a leader in ancillary services for the workers’ compensation industry and ancillary services for Medicare and Medicad, that eliminated nearly $1 billion of the company’s outstanding debt.

  • Trident's Chapter 11 Cases

    Silver Point Capital, as postpetition and senior prepetition lender, in the restructuring of Trident and its affiliates, the leading national provider of bedside diagnostic and related health care services, including its chapter 11 cases.

  • Egalet's Prearranged Chapter 11 Cases

    An ad hoc group of first lien noteholders of Egalet, a specialty pharmaceutical company, in Egalet's prearranged chapter 11 cases.

  • RCCH HealthCare Partners’ Acquisition of Kennewick Public Hospital District

    RCCH HealthCare Partners, a Tennessee-based provider of hospital and healthcare services, in its acquisition of substantially all of the assets of chapter 9 debtor Kennewick Public Hospital District (d/b/a Trios Health).

© 2023 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy